Key facts
- It has raised $7.5M; the latest was Seed Round ($7.5M) in Feb 2026.
- Notable investors include FJ Labs, Canary (Brazil), Flourish Ventures, Rally Cap VC, Canary Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Revena
- ·The full record, as it builds
Funding rounds
No funding rounds for Revena are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Revena
Developer of a generative artificial intelligence-based medical record system designed to automate healthcare billing procedures. The company's platform reads documents and automates billing calculations, reducing errors and significantly decreasing processing time, enabling clinics and laboratories to streamline medical billing operations and improve efficiency.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2024
- Employees
- 50
- Website
- revena.com.br/
- Ownership
- Privately Held (backing)
Revena doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Revena shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Revena in its N-PORT filings yet. We sweep new filings monthly.